Bromocriptine lowers intraocular pressure without affecting blood pressure. 1983

Q A Mekki, and S M Hassan, and P Turner

Oral bromocriptine (1.25 mg) was given to 8 healthy volunteers in a double-blind placebo controlled cross-over study. 3 and 4 h after taking the tablet there was a significant reduction in intraocular pressure but no change in pupil diameter. There were no changes in heart rate, blood pressure, and systolic time intervals in 6 other healthy volunteers within 3 h of being given 1.25 mg bromocriptine. These results suggest that dopamine receptors may be involved in the control of intraocular pressure.

UI MeSH Term Description Entries
D007429 Intraocular Pressure The pressure of the fluids in the eye. Ocular Tension,Intraocular Pressures,Ocular Tensions,Pressure, Intraocular,Pressures, Intraocular,Tension, Ocular,Tensions, Ocular
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D001971 Bromocriptine A semisynthetic ergotamine alkaloid that is a dopamine D2 agonist. It suppresses prolactin secretion. 2-Bromoergocryptine,Bromocryptin,2-Bromo-alpha-ergocryptine,2-Bromo-alpha-ergokryptine,2-Bromoergocryptine Mesylate,2-Bromoergocryptine Methanesulfonate,2-Bromoergokryptine,Bromocriptin,Bromocriptine Mesylate,CB-154,Parlodel,2 Bromo alpha ergocryptine,2 Bromo alpha ergokryptine,2 Bromoergocryptine,2 Bromoergocryptine Mesylate,2 Bromoergocryptine Methanesulfonate,2 Bromoergokryptine,CB 154,CB154,Mesylate, 2-Bromoergocryptine,Mesylate, Bromocriptine,Methanesulfonate, 2-Bromoergocryptine
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Q A Mekki, and S M Hassan, and P Turner
February 1984, Lancet (London, England),
Q A Mekki, and S M Hassan, and P Turner
January 1980, Investigative ophthalmology & visual science,
Q A Mekki, and S M Hassan, and P Turner
January 1986, Journal of ocular pharmacology,
Q A Mekki, and S M Hassan, and P Turner
January 1985, Ophthalmic research,
Q A Mekki, and S M Hassan, and P Turner
January 1988, American journal of ophthalmology,
Q A Mekki, and S M Hassan, and P Turner
August 1996, Journal of glaucoma,
Q A Mekki, and S M Hassan, and P Turner
January 2015, Translational vision science & technology,
Q A Mekki, and S M Hassan, and P Turner
November 1980, Investigative ophthalmology & visual science,
Q A Mekki, and S M Hassan, and P Turner
August 1976, Proceedings of the Royal Society of Medicine,
Copied contents to your clipboard!